Refractory follicular Non-Hodgkin's lymphoma
Also known as: Follicular Non-Hodgkin's Lymphoma Refractory / Refractory follicular non-hodgkin lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB06769 | Bendamustine | An antineoplastic agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed following rituximab therapy. |
DB00078 | Ibritumomab tiuxetan | A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06769 | Bendamustine | Cytochrome P450 1A2 | enzyme |
DB00078 | Ibritumomab tiuxetan | B-lymphocyte antigen CD20 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09054 | Idelalisib | Not Available | Completed | 1 |